PI
DGX icon

Placemark Investments’s Quest Diagnostics DGX Stock Holding History

Placemark Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$9.47M Buy
141,271
+24,218
+21% +$1.53M 0.17% 144
2014
Q3 		$7.1M Buy
117,053
+36,322
+45% +$2.24M 0.13% 188
2014
Q2 		$4.74M Buy
80,731
+22,936
+40% +$1.34M 0.08% 287
2014
Q1 		$3.35M Buy
57,795
+34,679
+150% +$1.86M 0.06% 361
2013
Q4 		$1.24M Buy
+23,116
New +$1.37M 0.02% 767

Other funds holding DGX

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Placemark Investments's DGX Position: Q4 2014 in Review

Placemark Investments increased its Quest Diagnostics (DGX) stake by 21% in Q4 2014, buying an estimated $1.53M and bringing the position to 141,271 shares worth $9.47M. The position accounts for 0.17% of the portfolio, ranked #144.

Placemark Investments first reported a position in DGX in Q4 2013 and has held it in 5 quarters since. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Placemark Investments held 141,271 shares of Quest Diagnostics worth $9.47M as of Q4 2014.
  • Placemark Investments bought 24,218 Quest Diagnostics shares in Q4 2014, an estimated $1.53M.
  • Quest Diagnostics made up 0.17% of Placemark Investments's portfolio in Q4 2014, its #144 holding.
  • Placemark Investments first reported a position in Quest Diagnostics in Q4 2013 and has held it in 5 quarters since.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.